Biotechnology
Cambridge, Massachusetts
2-10 employees
Founded 2021
About Parallel Bio
Parallel Bio is a biotechnology company that has developed a 'human immune system in a dish' platform to accelerate drug development. Leveraging immune organoids and AI, it provides services like preclinical drug testing and disease modeling to its clients in the pharmaceutical and biotech industries. The company's goal is to replace animal models and create more effective drugs from the start.
Company Classification
Customer Types
B2B
Business Models
Services
Product & Service Types
AI-powered immune organoid platformPreclinical drug testing servicesDisease modeling and target discovery
Funding
Total Funding
$4.63M
No. of Funding Rounds
2
Customers
| Customer | Success Story | Source |
|---|---|---|
| Parallel Bio actively works with these companies to solve problems in drug discovery and development using their proprietary technology. | ||
| Parallel Bio actively works with these companies to solve problems in drug discovery and development using their proprietary technology. |
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos